Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis.

TitelGenome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis.
MedientypJournal Article
Jahr der Veröffentlichung2021
AutorenTietz AK, Angstwurm K, Baumgartner T, Doppler K, Eisenhut K, Elisak M, Franke A, Golombeck KS, Handreka R, Kaufmann M, Kraemer M, Kraft A, Lewerenz J, Lieb W, Madlener M, Melzer N, Mojzisova H, Möller P, Pfefferkorn T, Prüss H, Rostásy K, Schnegelsberg M, Schröder I, Siebenbrodt K, Sühs K-W, Wickel J, Wandinger K-P, Leypoldt F, Kuhlenbäumer G
Corporate AuthorsGerman Network for Research on Autoimmune Encephalitis(GENERATE)
JournalNeurol Neuroimmunol Neuroinflamm
Volume8
Ausgabe6
Datum der Veröffentlichung2021 Nov
ISSN2332-7812
Zusammenfassung

BACKGROUND AND OBJECTIVES: To investigate the genetic determinants of the most common type of antibody-mediated autoimmune encephalitis, anti-NMDA receptor (anti-NMDAR) encephalitis.

METHODS: We performed a genome-wide association study in 178 patients with anti-NMDAR encephalitis and 590 healthy controls, followed by a colocalization analysis to identify putatively causal genes.

RESULTS: We identified 2 independent risk loci harboring genome-wide significant variants ( < 5 × 10, OR ≥ 2.2), 1 on chromosome 15, harboring only the gene, and 1 on chromosome 11 centered on the and genes in a larger region of high linkage disequilibrium. Colocalization signals with expression quantitative trait loci for different brain regions and immune cell types suggested , , , , and as putatively causal genes. The best candidate genes in each region are , encoding leucine-rich repeat kinase 1, a protein involved in B-cell development, and liver X receptor alpha, a transcription factor whose activation inhibits inflammatory processes.

DISCUSSION: This study provides evidence for relevant genetic determinants of antibody-mediated autoimmune encephalitides outside the human leukocyte antigen (HLA) region. The results suggest that future studies with larger sample sizes will successfully identify additional genetic determinants and contribute to the elucidation of the pathomechanism.

DOI10.1212/NXI.0000000000001085
Alternate JournalNeurol Neuroimmunol Neuroinflamm
PubMed ID34584012
PubMed Central IDPMC8479862